%0 Journal Article
%T Profile of Parkinson¡¯s Patients with Major Cognitive Deficits Received for Consultation at the Ibrahima Pierre Ndiaye Neuroscience Clinic at the CHNU de Fann in 2022
%A Adoum Hamad Zenal Abidine
%A Soumaila Boubacar
%A Carlos Othon Guelngar
%A Kadji Juste Milman
%A Kamadore Toure
%J Open Access Library Journal
%V 12
%N 6
%P 1-7
%@ 2333-9721
%D 2025
%I Open Access Library
%R 10.4236/oalib.1113539
%X Introduction: Major cognitive deficits are common in Parkinson¡¯s disease, especially in the advanced stages. The objective of this study was to determine the profile of Parkinson¡¯s patients with major cognitive deficits seen at the Neurosciences Clinic. Patients and Methods: This is a 3-month cross-sectional study (March-June 2022). Parkinson¡¯s patients meeting the MDS (Movement Disorder Society) criteria were included in the study. They underwent a neuropsychological assessment (Senegal Test score ¡Ü 28/39) and ADL assessment (Keur Madiabel Test score ¡Ü 5/6), considered to have a major cognitive deficit according to DSM5. Results: We identified 257 patients, 56 of whom presented with major cognitive impairment, representing a frequency of 21.7% and an adjusted frequency of 23.3%. They were predominantly male (46 cases, or 82%). The mean age was 74.6 ¡À 15 years. The age group of 60 - 80 years was the most affected. Shopkeepers (46%) were the most represented. Hypertension was found in (46%) of cases. The mode of onset was progressive (93%). Executive/visuospatial functions (66.1%) and memory (37.5%) were the most impaired cognitive domains. All patients were on L-Dopa to treat motor symptoms. Conclusion: The assessment of Parkinson¡¯s patients with the Senegal Test and the Keur Madiabel Test is of value in the management of major cognitive deficits.
%K Parkinson¡¯s Disease
%K Major Cognitive Deficits
%K Senegal Test
%K Keur Madiabel Test
%K Senegal
%U http://www.oalib.com/paper/6861073